The aim of the Education Committee (EC) is to coordinate ESOTโs efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
ECTORS, the European Cell Therapy and Organ Regeneration Section of ESOT, would like to announce a call for nominations for two new Board members. ESOT/ECTORS members active in the field of regenerative medicine or cell therapy are eligible to submit their applications for the positions. The Board reserves the right to shortlist candidates on the
Extended deadline for the #ITSmeeting abstract submission: 19 January 2022 [at 23:59 CET]
This educational webinar will discuss the efficacy of current COVID-19 vaccine strategies for transplanted patients. The first talk will focus on the experience with heterologous vaccinations and the proยดs and conยดs for vector vaccines in transplant patients. The second talk summarises previous studies on second and third booster (homogenous and heterologous) vaccinations โ and gives
We would like to announce a call for nominations for two new Board members. ESOT/ECTORS members active in the field of regenerative medicine or cell therapy are eligible to submit their application for the positions. The Board reserves the right to shortlist candidates on the basis of their specialty. If you wish to apply, please
REGISTER TODAY โ CLICK HERE Registration to 2nd ECTORS Meeting is complimentary, but only registered participants will have access. The Programme is available here
The abstract submission deadline for #ESOTcongress has been EXTENDED until Thursday 25th February at 23:59 CET.
Transplant patients are exceptionally vulnerable to all infections, especially COVID-19, due to immunosuppression and other co-morbidities. There is a clear need for these patients to receive the best available protection against COVID-19 and we strongly believe that they should be considered as a priority group for vaccination across Europe. Furthermore, our patients and the broader
ESOT is seeking a publisher for its flagship scientific journal, Transplant International, to discuss the transition to an open access journal.
We are pleased to announce that our TLJ 2.0 report has been published and is available to read now. Providing a comprehensive summary of TLJ 2.0, this report covers all the highlights from the event, including the key discussion points and outcomes from some of the Worldโs leading transplant experts. Read the TLJ20Report for the
ESOT is pleased to announce a new initiative in collaboration with the Centre for Evidence in Transplantation (CET), allowing 40 prospective abstract submitters to receive preliminary feedback on their abstract to help enhance the quality and increase the chances of being accepted to the Congress. Please see the process and deadlines below: Any prospective abstract
